LUMINEX CORPORATION ENDORSES ANTEO’S MIX&GOTM AMG ACTIVATION KIT
Anteo Technologies Pty Ltd, a wholly owned subsidiary of Anteo Diagnostics Ltd (ASX:ADO), is pleased to provide shareholders with the link to a blog postedi by Luminex Corporation that describes the performance and benefits of using Anteo Mix&GoTM (AMG) Activation Kit for Multiplex Microspheres on the Luminex xMAP platform.
In line with Anteo Technologies’ product pipeline development strategy, the company launched the AMG Activation Kit for Multiplex Microspheres in December 2014 to assist users of Luminex systems to more easily transfer their existing ELISA assays onto the Luminex platform. The AMG Activation Kit also allows users to troubleshoot proteins that are difficult to attach to Luminex microspheres using other methods.
As previously reported, a number of Luminex partners are now engaged with Anteo and one is engaged in a study with clinical samples that is scheduled to conclude this quarter.
Dr Geoff Cumming, CEO Anteo Technologies commented: “This blog post is a solid endorsement of Mix&Go and evidence that our technology is gaining sound industry recognition. We expect to launch more AMG kits in the near term which is in line with our goal of launching one new AMG kit each quarter.”
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)